Article

New Issue Alert: Lung Cancer Special Issue #2

Here’s a look at what’s inside our November 2019 Lung Cancer special issue.

Here’s a look at what’s inside our November 2019 Lung Cancer special issue:

In non-small cell lung cancer, 16 to 20 percent of all cases will include disease that has spread to the brain. So what treatment options are available to these patients? Inside this issue, CURE explore the new therapies that can help when cancer goes Beyond the Lungs.

Next, most people have never heard of paraneoplastic syndromes, but these diseases can be brought on by cancer, and they’re particularly prevalent in lung cancer. Our feature story shares the Strange Signs that can occur and how these syndromes can be treated.

And, hear from three lung cancer survivors, who have not only outlived the disease they thought would claim their lives but are also thriving day to day. CURE talks with them as they reach seven and 15 years past their advanced lung cancer diagnosis.

To read these stories and more, visit the Lung Cancer Special Issue online.

Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email[dash]profile for more information.

And, as always, thanks for reading.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content